7321 - 7330 of 8808 Results
Title
Year
-
OPENTitle: Mental health in people with Parkinson’s disease during the COVID-19 pandemic: potential for targeted interventions?Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00238-yBest OA location URL: https://www.nature.com/articles/s41531-021-00238-y.pdfCitation Count: 20
-
OPENTitle: Temporal proteomics during neurogenesis reveals large-scale proteome and organelle remodeling via selective autophagyJournal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 24Start Page: 5082End Page: 5098.e11Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.molcel.2021.10.001Best OA location URL: http://www.cell.com/article/S1097276521008005/pdfCitation Count: 83
-
OPENTitle: Contribution of rare variant associations to neurodegenerative disease presentationJournal Name: npj Genomic MedicinePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41525-021-00243-3Best OA location URL: https://www.nature.com/articles/s41525-021-00243-3.pdfCitation Count: 20
-
OPENTitle: Carlos II of Spain, ‘The Bewitched’: cursed by aspartylglucosaminuria?Journal Name: BMJ Neurology OpenPublisher: BMJVol: 3Issue #: 2Start Page: e000072End Page: e000072Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjno-2020-000072Best OA location URL: https://neurologyopen.bmj.com/content/bmjno/3/2/e000072.full.pdfCitation Count: 1
- Factors associated with impaired quality of life three months after being diagnosed with COVID-192021OPENTitle: Factors associated with impaired quality of life three months after being diagnosed with COVID-19Journal Name: Quality of Life ResearchPublisher: Springer Science and Business Media LLCVol: 31Issue #: 5Start Page: 1401End Page: 1414Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11136-021-02998-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11136-021-02998-9.pdfCitation Count: 35
-
OPENTitle: Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum ExposureJournal Name: Advanced SciencePublisher: WileyVol: 8Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202101462Best OA location URL: https://doi.org/10.1002/advs.202101462Citation Count: 140
-
OPENTitle: Structural basis for membrane recruitment of ATG16L1 by WIPI2 in autophagyJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.70372Best OA location URL: https://doi.org/10.7554/elife.70372Citation Count: 45
- Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS Study2021OPENTitle: Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1853End Page: 1862Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28596Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28596Citation Count: 38
-
OPENTitle: Altered Brain Functional Network in Subtypes of Parkinson's Disease: A Dynamic PerspectiveJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.710735Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.710735/pdfCitation Count: 24
-
OPENTitle: A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.705407Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.705407/pdfCitation Count: 67